Companies /Healthcare

Aurora Cannabis Inc

NASDAQ: ACB Drug Manufacturers - Specialty & Generic
$4.52
▼ $0.09 (−1.95%) today
Markets closed · 6:35pm ET

ACB at a Glance

Valuation
Market cap
$303.1M
Profitability
Revenue (TTM)
$314.1M
Profit margin
-38.3%
EPS (TTM)
$-0.18
Price
52-week range
$3 – $6
Street target
$6.23

Headquartered in Edmonton, AB Fiscal year ends March NASDAQ: ACB auroramj.com

About Aurora Cannabis

Aurora Cannabis Inc. is a vertically integrated cannabis company focused on medical cannabis. Its operations span cultivation, manufacturing, packaging and distribution, supported by research and development, genetics and breeding, and patient counselling services.

The company has three main lines of activity:
- **Canada:** produces, distributes and sells medical cannabis under the Cannabis Act. Its Canadian consumer cannabis channel is being wound down.
- **European Union:** produces and distributes wholesale medical cannabis under German medicinal and narcotics laws, including from its Leuna, Germany facility.
- **Other international markets:** distributes wholesale medical cannabis, including in Australia, New Zealand, Poland and the United Kingdom.

It reports one operating segment, Cannabis. Sales channels are Canadian medical, international medical, Canadian consumer and wholesale bulk. International medical sales, led by Germany and Poland, are now the largest revenue driver.

Cultivation facilities include Alpine in Pemberton, British Columbia, River in Markham, Ontario, and Leuna in Germany.

In fiscal 2027 Aurora made two acquisitions:
- Safari Flower Company, adding EU-GMP certified cultivation capacity.
- UK-based Internode Pharma (importer/wholesaler) and HAP Pharma (pharmacy), giving it control of UK distribution.

It divested its 50.1% interest in Bevo Agtech, a plant propagation business, in February 2026. Its shares trade on Nasdaq and the TSX under 'ACB' and on the Frankfurt Stock Exchange.

In November 2026 Aurora agreed to be acquired by Organigram Global Inc., after its board recommended rejecting an unsolicited bid from Curaleaf. Updated

ACB Coverage

Frequently Asked Questions

What does Aurora Cannabis do?

Aurora Cannabis Inc. is a vertically integrated cannabis company focused on medical cannabis. Its operations span cultivation, manufacturing, packaging and distribution, supported by research and development, genetics and breeding, and patient counselling services.

What is the ACB stock price target?

The Wall Street consensus 12-month price target for ACB is $6.23.